George Moore
Endocrinology, Diabetes & Metabolism · Bothell, WANPI 1588604110
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $40,725 of the $54,995 with a category attached, or 74.1%. Amgen accounts for 72.9% of it on its own, with 35 other manufacturers making up the rest. Reporting peaked in 2019 at $51,034 and has fallen 97.0% since, to $1,511 in 2021. Among endocrinology, diabetes & metabolism clinicians in WA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 395 payments — averaging $139.23 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Amgen$40K
- Sanofi-aventis U.S. LLC$11K
- Novo Nordisk$590
- Antares Pharma, Inc.$476
- Amarin Pharma, Inc.$408
- AstraZeneca$349
- plus $2K from 30 others
What the payments were for
- Speaking & faculty fees$40,72574%
- Travel & lodging$7,22413%
- Food & beverage$6,98513%
- Education$610%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Amgen | 83 | $40,085 |
| Sanofi-aventis U.S. LLC | 38 | $10,770 |
| Novo Nordisk | 41 | $590 |
| Antares Pharma, Inc. | 41 | $476 |
| Amarin Pharma, Inc. | 22 | $408 |
| AstraZeneca(2 entities) | 20 | $349 |
| Dexcom, Inc. | 18 | $308 |
| Lilly USA, LLC | 22 | $266 |
| Boehringer Ingelheim | 30 | $245 |
| IBSA Pharma Inc. | 11 | $182 |
| AbbVie | 8 | $157 |
| Johnson & Johnson | 5 | $103 |
| Kowa Pharmaceuticals America, Inc. | 6 | $99 |
| Corcept Therapeutics | 6 | $88 |
| Abbott | 3 | $84 |
| Esperion Therapeutics, Inc. | 4 | $73 |
| Lifescan, Inc. | 4 | $73 |
| Insulet Corporation | 3 | $73 |
| Arbor Pharmaceuticals, Inc. | 4 | $63 |
| Regeneron Healthcare Solutions, Inc. | 3 | $55 |
| Alfasigma USA, Inc. | 3 | $52 |
| Vistapharm, Inc. | 2 | $49 |
| Ultragenyx Pharmaceutical Inc. | 2 | $48 |
| Medicure Pharma Inc. | 1 | $43 |
| Radius Health, Inc. | 2 | $39 |
| Merck | 2 | $29 |
| Companion Medical, Inc. | 2 | $29 |
| Medtronic | 1 | $27 |
| Zealand Pharma US, Inc. | 1 | $23 |
| Ferring Pharmaceuticals Inc. | 1 | $22 |
| Mannkind Corporation | 1 | $21 |
| Novartis | 1 | $17 |
| Aegerion Pharmaceuticals, Inc. | 1 | $14 |
| Xeris Pharmaceuticals, Inc. | 1 | $13 |
| Pfizer | 1 | $12 |
| Acella Pharmaceuticals, LLC | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Prolia$26,310
- EVENITY$12,456
- SOLIQUA 100/33$7,494
- TOUJEO$5,905
How this compares
$54,995 in reported general payments places this provider in the 90th percentile of 161 endocrinology, diabetes & metabolism providers in Washington.
See all endocrinology, diabetes & metabolism providers in Washington →
Other endocrinology, diabetes & metabolism in Bothell
- Michael ShannonLacey$698K
- Lynn KohlmeierSpokane$518K
- Carol WyshamSpokane$512K
- Bruce WilsonRichland$352K
- Irl HirschSeattle$192K
- Biju KunhiramanYakima$118K
- Nicole EhrhardtSeattle$111K
- Kristina UtzschneiderSeattle$72K
- Savitha SubramanianSeattle$71K
- Sonia HansKirkland$70K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.